Long-term Safety of PF-00345439 (Oxycodone)
- First Posted Date
- 2012-03-21
- Last Posted Date
- 2015-09-11
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 823
- Registration Number
- NCT01559701
A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 21
- Registration Number
- NCT01552863
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, New Haven, Connecticut, United States
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 18
- Registration Number
- NCT01552850
- Locations
- ๐ธ๐ฌ
Pfizer Investigational Site, Singapore, Singapore
Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
Phase 1
Completed
- Conditions
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2011-07-14
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 21
- Registration Number
- NCT00734188
- Locations
- ๐ฎ๐ฑ
Hadassah Hebrew University Hospital, Jerusalem, Israel
Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 14
- Registration Number
- NCT00734461
- Locations
- ๐บ๐ธ
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States
Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2011-07-14
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 12
- Registration Number
- NCT00399113
- Locations
- ๐ฎ๐ฑ
Hadassah Hebrew University Hospital, Jerusalem, Israel
๐ฎ๐ฑChaim Sheba Medical Center, Tel Hashomer, Israel
ยฉ Copyright 2024. All Rights Reserved by MedPath